Angiolite

Coronary sirolimus stent
The DES we trust

PRODUCT FEATURES

Excellent performance even in compromised situations

Left Main and bifurcation lesions: One of the highest overexpansion capacity for large vessels ​ 6.00mm

75​µm
Small vessels:
Adapted to the need of the arteries with thin struts

Diffuse lesions: new available lengths 44 & 49mm

Calcified lesions: excellent arterial support +40% vs competitors

High quality of healing

TransferWise, the iVascular proprietary technology that provides a homogenous drug elution that translates into lower rates of restenosis and inflammation score.

Our fluoro-acrylate polymer provides an early endothelialization and creates a thromboresistant layer. This mechanism suggest to reduce stent thrombosis.

 

CLINICAL SUPPORT

Angiolite has proven its safety and efficacy in the following clinical trials and registries

ANCHOR Study

Observational, prospective, multicenter study​ 86.3% Strut coverage at 3 months​

ANGIOLITE Trial

Randomized, non-inferiority, observational, prospective, multicenter trial 0.04mm LLL at 6 months​

RANGO Registry

Prospective, single arm, multicenter observational registry ​ 3.4% TLF at 2 year ​